Participated · Series B · Aug 2022

Raven360 offers Digital Academies that let marketing teams embed knowledge-rich learning environments into their websites so prospects can research, demo and purchase products on their own terms. By aligning seller content with buyer problems from the first interaction, the platform turns web visitors into informed product evaluators and ultimately qualified leads. These academies generate predictive insights into each prospect’s stage in the buying journey, enabling marketing and sales teams to support buyer-led purchases more effectively. Fast-growing companies worldwide use Raven360 to onboard, teach, coach and inspire customers, partners and employees. With its newly raised capital, the company will expand sales and marketing, enhance the user experience and interface, and integrate machine-learning and AI capabilities to deepen engagement. Headquartered in Marlborough, Massachusetts, Raven360 positions itself as a critical tool in the modern CMO’s toolkit for creating top-of-funnel opportunities.

Participated · Series B · Jan 2022

CRIO offers an enterprise-grade eClinical platform that centralizes site data capture and research workflows with fully integrated eSource, site CTMS, eConsent, EDC, remote monitoring, and source data verification. The platform targets research sites, sponsors, and CROs and has attracted a rapidly growing base of hundreds of customers. CRIO’s integrated direct data capture solution aims to reduce costs, speed trial conduct, and improve data quality by eliminating transcription and automating site financial and compliance functions. The company emphasizes a patient-centric, intuitive user experience and reduced site burden as core design principles. The recent investment is intended to fund expanded product development, broaden the product suite, international expansion, and enhanced customer support. CRIO positions itself as a challenger to incumbent clinical trial data-capture and site workflow methods. CRIO focuses on streamlining regulatory workflows with a single source of clinical data capture for sponsors, sites and patients. Its modules allow sites to capture data electronically in real time, giving data managers and monitors enhanced transparency. The platform enables remote monitoring by sponsors and CROs. CRIO plans to use new funding to expand its product, engineering, and business development teams to develop and market products. The company is positioning its tech to simplify trial operations and improve visibility across stakeholders. Financially, CRIO has just closed a new financing round to support that growth. Clinical Research IO (CRIO) is a Boston-based health tech company that provides a clinical-trial workflow platform for research sites, hospitals, biotech and pharma. Its platform offers paperless binders and an electronic delegation log, with modules that enable sites to capture data in real time. That real-time capture provides enhanced transparency and enables remote monitoring by sponsors and CROs. Led by co-founder and CEO Raymond Nomizu, the company launched in 2016 and has since been adopted by over 600 research sites globally. In 2020 CRIO more than doubled its revenue and acquired over 600 research sites across 12 countries. It plans to use the new funding to expand product and engineering teams to develop the next wave of products. CRIO builds an e-source platform — a website and Android app — that enables researchers to conduct clinical research site visits remotely via tablet or desktop, configure e-source templates, capture data, manage and schedule subjects, and communicate with study monitors. The product is designed to replace pen-and-paper workflows and reduce manual data entry and verification, improving the quality and speed of source data capture. CRIO targets pharmaceutical companies and clinical research sites and has partnered with Medidata through the eConnect partner program. The company raised $1.6 million to support pilot studies with pharmaceutical companies and to expand operations. Proceeds will be used to support pilot studies and grow headcount from five to 11 across customer service, sales, and software support. Earlier this year CRIO also raised an $800,000 seed round led by the same venture firms.

Participated · Series A · Jul 2019

Connectbase operates the Connected World platform, an operating system that enables service providers and partners to discover, quote, transact and manage connectivity services across more than 2.2 billion locations and 400+ network providers worldwide. By combining detailed location intelligence with automated quoting tools, the company helps carriers and enterprises speed up transactions and improve accuracy. The newly announced acquisition of Cloud Age adds telecom invoice automation and spend-management capabilities that serve over 1,700 vendors, extending Connectbase’s workflow from “quote to cash” through “procure to pay.” This integration is intended to deliver a single, federated digital fabric that supports ecosystem-led growth and future agentic or autonomous systems. The company plans to leverage Cloud Age’s expertise in billing data to offer providers actionable spend intelligence and profitability insights. Connectbase’s strategy centers on expanding its platform’s global reach, enhancing automation, and deepening its software and data assets. The recent growth investment from Equality Asset Management will finance the Cloud Age purchase and accelerate ongoing product innovation and international expansion.

Participated · Seed · Dec 2018

Ambi builds a Learner Engagement Platform that reimagines the higher-education student experience by putting students at the center of learning. Its interface is designed to feel like the social networks students use, with tight integrations to course materials and learning management systems such as Canvas and Blackboard. The product is the result of three years of research and more than eighteen months of development and is built with student privacy and safety in mind, compliant with FERPA and WCAG 2.0. Ambi positions itself as a private, productive social network for college that focuses on productivity, communication, and community formation. The company has said it aims to be a global leader in centralized digital learning from college prep through higher education and was selected to present at the 2019 ASU GSV Summit Growth Track. Ambi also added Mark Blosil as Senior Vice President of Sales and closed $6.5M in combined Series A and seed funding.

Led · Series A · Oct 2018

Chasm develops and manufactures advanced materials for printed electronics and battery applications, including a transparent conductive film (TCF) called AgeNT. AgeNT is a hybrid of carbon nanotubes (CNTs) and silver nanowires (AgNWs) positioned as a printed hybrid TCF to compete with indium tin oxide (ITO). The company says hybrid TCFs offer superior performance—being more conductive and more flexible—while reducing costs by enabling circuit patterns via commercial printing methods. Uses cited include touchscreens, transparent electrodes for displays and solar panels, touch sensors for appliances and automotive interiors, transparent heaters for defogging, and transparent EMI shielding for industrial and medical devices. Chasm completed an $11M Series A financing and intends to use the funds to expand production capabilities and continue launching new products to penetrate large existing markets. The company is led by CEO and co-founder David Arthur and has an R&D center and manufacturing plant in Norman, Oklahoma, while being based in Canton, Massachusetts.